(Q37731451)

22 August 2017

The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells (English)

1 reference

22 August 2017

1 reference

Maithao N Le

1

1 reference

22 August 2017

Joseph L-K Chan

2

1 reference

22 August 2017

Stephen A Rosenberg

3

1 reference

22 August 2017

Adam S Nabatian

4

1 reference

22 August 2017

Kim T Merrigan

5

1 reference

22 August 2017

Karine A Cohen-Solal

6

1 reference

22 August 2017

James S Goydos

7

1 reference

22 August 2017

language of work or name

English

0 references

publication date

27 May 2010

1 reference

Journal of Investigative Dermatology

22 August 2017

1 reference

22 August 2017

130

1 reference

22 August 2017

9

1 reference

22 August 2017

2240-2249

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.126

22 August 2017

0 references

cites work

Treatment for metastatic malignant melanoma: old drugs and new strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Treatment of metastatic melanoma: an overview

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Novel therapeutics for the treatment of metastatic melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Genetic subgrouping of melanoma reveals new opportunities for targeted therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

The future of tyrosine kinase inhibitors: single agent or combination?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Metabotropic glutamate receptors (mGlus) and cellular transformation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

23 August 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Diagnosis and treatment of cutaneous melanoma: state of the art 2006.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Advances in clinical trials for amyotrophic lateral sclerosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Identification and functional roles of metabotropic glutamate receptor-interacting proteins

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Focal adhesion kinase promotes the aggressive melanoma phenotype.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

New ideas for therapy in ALS.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4004181

Riluzole for ALS: what is the evidence?

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20505744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20505744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FJID.2010.126

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JID.2010.126

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference

22 August 2017

1 reference